Indonesia gets 1.1 million AstraZeneca vaccine doses via COVAX
Mar 11 2021
Australia started its vaccination drive much later than many countries as border closures, snap lockdowns and speedy tracing systems kept cases relatively low compared with many other developed countries. "We saw it after July Fourth", she said.
Meanwhile, former European Union member Britain reopened its schools as a tough lockdown and successful first-jabs programme brought daily infection numbers down 90 percent from where they were two months ago.
"His condition is not considered to be related to the vaccine", the office said, as quoted in the report.
Australia's most senior health officials are set to be grilled about the coronavirus vaccine rollout which is falling short of lofty government targets. Two masks for vaccinated individuals, however, may be unnecessary, Pelletier said.
Emergency medicine specialist Dr. Paik Jin-hui, who is in his 40s, was inoculated with a Pfizer vaccine on Monday, and said he was "feeling completely fine".
The government has ordered vaccines produced overseas from Pfizer and AstraZeneca, and it has also arranged for the AstraZeneca vaccination to be produced by chemical manufacturer CSL in Melbourne.
Most often, patients complained of a headache after vaccination (22.9%), dizziness (16.8%), and fatigue (16.8%).
Out of the over 500,000 people who have been given their first shots of the COVID-19 vaccine in Korea, 6,859 have reported experiencing suspected side effects, according to Korea Disease Control and Prevention Agency statistics.
Signs of economic revival in the United States - where vaccinated people can now mingle unmasked per the latest medical recommendation - also point to the world's wealthier countries aiming for a mid-year bounceback from the pandemic. With Dr. B, she said, "I know that they're calling at least what we think is the right group of people to come get those shots, so that we don't have to ever waste any".
Investigations so far have revealed no links between the adverse events and the vaccines. In Phase 3 trials, both vaccines reported high efficacy in preventing symptomatic COVID-19 infections after two doses given three to four weeks apart.
In recent days, the Italian government blocked the export to Australia of 250,000 doses of the vaccine, produced at an AstraZeneca facility in Italy.
"If the world's scientists were able to develop safe and effective vaccines in just seven months, the aims of world's leaders must be equally record-breaking - to provide enough funding and to ramp up manufacturing to enable everyone on earth to be vaccinated", said UN Under-Secretary-General for Global Communications Melissa Fleming.
Mounting public pressure to have vaccines unlock a semblance of pre-pandemic life is being felt by Europe's leaders.